Form D · Other Technology

Greenlight Biosciences Inc.

Medford, MA · CIK 0001583880

Offering snapshot reported Jun 26, 2020 · SEC filing

Reported sold
$103M
Offering amount: $110M
Investors reported
19
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 15, 2020
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 26, 2020Initial$102,549,979No comparison19SEC filing
Dec 19, 2018Initial$38,749,998No comparison15SEC filing
Sep 14, 2017Initial$9,999,995No comparison10SEC filing
Jun 16, 2015Initial$20,007,507No comparison7SEC filing
Dec 20, 2013Amendment$8,045,815$1,045,815vs Aug 9, 20133SEC filing
Aug 9, 2013Initial$7,000,000No comparison2SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-369820

Source: Form D, filed Jun 26, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
William Blake Executive
Charles Cooney Director
Jason Dinges Director
Jonathan Fleming Director
David Furneaux Director
Ganesh Kishore Director
Michael Liang Director
Greg Lucier Director
Eric O'brien Director
Marta Ortega Valle Executive
Neil Renninger Director
Martha Schlicher Director
James Swartz Director
Matthew Walker Director
Andrey Zarur Director, Executive

Issuer details

Industry: Other Technology (See others in industry)

Address:
200 Boston Avenue Suite 3100
Medford, MA, 02155